Milnacipran Side Effects
Some side effects of milnacipran may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to milnacipran: oral tablet
Get emergency medical help if you have any of these signs of an allergic reaction while taking milnacipran: skin rash or hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Report any new or worsening symptoms to your doctor, such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.
Call your doctor at once if you have any of these serious side effects:
pounding heartbeats or fluttering in your chest;
painful or difficult urination;
easy bruising or bleeding, nosebleeds, bloody or tarry stools, coughing up blood;
severe weakness, seizure (convulsions);
chills or goose bumps, memory problems, trouble concentrating,
agitation, hallucinations, fast heart rate, overactive reflexes, nausea, vomiting, diarrhea, loss of coordination, fainting;
very stiff (rigid) muscles, high fever, confusion, fast or uneven heartbeats, tremors, feeling like you might pass out;
high blood pressure (severe headache, blurred vision, buzzing in your ears, chest pain, shortness of breath, uneven heartbeats); or
stomach pain, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).
Less serious side effects of milnacipran may include:
dizziness, drowsiness, tired feeling;
swelling in your hands or feet;
constipation, upset stomach, bloating;
sleep problems (insomnia);
hot flashes, sweating;
weight changes; or
decreased sex drive, impotence, or difficulty having an orgasm.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to milnacipran: oral tablet
Very common (10% or more): Nausea (35%), constipation (16%),
Common (1% to 10%): Vomiting (6%), dry mouth (5%), abdominal pain (3%)
Uncommon (0.1% to 1%): Decreased appetite (1%)
Frequency not reported: Anorexia, diarrhea, dyspepsia, gastroesophageal reflux disease, flatulence, abdominal distension
Very common (10% or more): Headache (19%), dizziness (11%)
Common (1% to 10%): Migraine (6%), paresthesia (2%), tremor (2%), tension headache (2%), hypoesthesia (1%)
Frequency not reported: Night sweats, somnolence, dysgeusia, fatigue, convulsions (including grand mal), loss of consciousness, neuroleptic malignant syndrome, Parkinsonism, serotonin syndrome
Very common (10% or more): Insomnia (12%)
Common (1% to 10%): anxiety (5%)
Frequency not reported: Aggression, depression, stress, anger, delirium, hallucinations, homicidal ideation, irritability
Common (1% to 10%): Palpitations (8%), hypertension (7%), increased heart rate (5%), increased blood pressure (3%), tachycardia (3%), chest pain (3%), chest discomfort (2%)
Postmarketing reports: Supraventricular tachycardia, hypertensive crisis
Common (1% to 10%): Hyperhidrosis (8%), rash (3%), pruritus (3%)
Frequency not reported: Night sweats, erythema multiforme, Stevens Johnson syndrome
Common (1% to 10%): Upper respiratory tract infection (7%), upper respiratory tract infection (6%), dyspnea (2%)
Common (1% to 10%): Blurred vision (1%)
Frequency not reported: Accommodation disorder
Common (1% to 10%): Reported in at least 2% of males: Dysuria, ejaculation disorder, erectile dysfunction, ejaculation failure, decreased libido, prostatitis, scrotal pain, testicular pain, testicular swelling, urinary hesitation, urinary retention, urethral pain, decreased urine flow, cystitis, galactorrhea
Frequency not reported: Urinary tract infection
Frequency not reported: Contusion, fall, physical dependence
Milnacipran produces physical dependence, including withdrawal symptoms following drug discontinuation, similar to other SNRIs and SSRIs. These withdrawal symptoms can be severe.
Very common (10% or more): Hot flush (11%)
Common (1% to 10%): Flushing (2%), chills (1%)
Frequency not reported: Weight decreased or increased, hypercholesterolemia, hyponatremia, pyrexia, peripheral edema
Frequency not reported: Urinary tract infection, cystitis, acute renal failure
Frequency not reported: Leukopenia, neutropenia, thrombocytopenia
Frequency not reported: Hyperprolactinemia, galactorrhea
Frequency not reported: Hepatitis
Frequency not reported: Rhabdomyolysis
More milnacipran resources
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.